These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26763341)

  • 41. Daptomycin-Related Rhabdomyolysis Complicated by Severe Hyperkalemia and Acute Kidney Injury.
    Nishimura Y
    Cureus; 2022 Sep; 14(9):e29764. PubMed ID: 36324366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Azithromycin-induced liver injury.
    Lockwood AM; Cole S; Rabinovich M
    Am J Health Syst Pharm; 2010 May; 67(10):810-4. PubMed ID: 20479103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection.
    Yusuf E; Perrottet N; Orasch C; Borens O; Trampuz A
    Surg Infect (Larchmt); 2014 Dec; 15(6):834-7. PubMed ID: 25317960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
    Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of N-Acetylcysteine for Clozapine-Induced Acute Liver Injury: A Case Report and Literature Review.
    Shah J; Muir J; Furfaro D; Beitler JR; Dzierba AL
    J Pharm Pract; 2023 Apr; 36(2):463-467. PubMed ID: 34284670
    [No Abstract]   [Full Text] [Related]  

  • 46. Successful clinical use of daptomycin-impregnated bone cement in two-stage revision hip surgery for prosthetic joint infection.
    Cortes NJ; Lloyd JM; Koziol L; O'Hara L
    Ann Pharmacother; 2013 Jan; 47(1):e2. PubMed ID: 23324502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second-generation thiazolidinediones and hepatotoxicity.
    Marcy TR; Britton ML; Blevins SM
    Ann Pharmacother; 2004 Sep; 38(9):1419-23. PubMed ID: 15266041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of Corynebacterium striatum endocarditis with daptomycin plus rifampin.
    Shah M; Murillo JL
    Ann Pharmacother; 2005 Oct; 39(10):1741-4. PubMed ID: 16144879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Daptomycin in the treatment of Gram-positive infections in patients with chronic renal failure].
    Sarriá Cepeda C
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():38-42. PubMed ID: 22541974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.
    Schutt AC; Bohm NM
    Ann Pharmacother; 2009 Dec; 43(12):2108-12. PubMed ID: 19887592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis.
    Bhavnani SM; Rubino CM; Ambrose PG; Drusano GL
    Clin Infect Dis; 2010 Jun; 50(12):1568-74. PubMed ID: 20462352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Falcone M; Russo A; Venditti M; Novelli A; Pai MP
    Clin Infect Dis; 2013 Dec; 57(11):1568-76. PubMed ID: 24046298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
    Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
    J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Daptomycin-induced eosinophilic pneumonia treated with intravenous corticosteroids.
    Chiu SY; Faust AC; Dand HM
    J Pharm Pract; 2015 Jun; 28(3):275-9. PubMed ID: 25657193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C
    Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM; Rojtman AD
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis.
    Riser MS; Bland CM; Rudisill CN; Bookstaver PB
    Ann Pharmacother; 2010 Nov; 44(11):1832-5. PubMed ID: 20959502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.